Pharmaceutical

Filter

Current filters:

None

Popular Filters

76 to 100 of 7208 results

Boehringer’s Ofev approved in EU for the treatment of IPF

19-01-2015

German family-owned pharma major Boehringer Ingelheim revealed today that the European Commission has…

Boehringer IngelheimEuropeOfevPharmaceuticalRegulationRespiratory and Pulmonary

ACOSS proposes alternative evidence-based and equitable savings to Australian health services

19-01-2015

The Australian Council of Social Service (ACOSS) has called on the federal government to heed the growing…

AustraliaFinancialHealthcarePharmaceutical

Addex Therapeutics teams up with Dystonia Medical Research Foundation on dipraglurant

Addex Therapeutics teams up with Dystonia Medical Research Foundation on dipraglurant

19-01-2015

Swiss pharma company Addex Therapeutics is to enter into a collaboration with the Dystonia Medical Research…

Addex PharmadipraglurantNeurologicalPharmaceuticalResearch

Novo Nordisk chooses Switzerland as first country to launch Xultophy

Novo Nordisk chooses Switzerland as first country to launch Xultophy

19-01-2015

Danish diabetes care giant Novo Nordisk has launched Xultophy (IDegLira) for people with type 2 diabetes…

DiabetesMarkets & MarketingNovo NordiskPharmaceuticalSwitzerlandXultophy

Janssen among groups in Innovative Medicines Initiative consortia to accelerate Ebola program

Janssen among groups in Innovative Medicines Initiative consortia to accelerate Ebola program

19-01-2015

US health care giant Johnson & Johnson’s Europe-based subsidiary has formed consortia with several…

Anti-viralsEuropeJanssenPharmaceuticalResearchVaccines

The first Sabin IPV approved by China FDA

19-01-2015

The China Food and Drug Administration (CFDA) on January 14 approved the production of the first inactivated…

ChinaPharmaceuticalProductionRegulationVaccines

UCB signs up to $480 million global collaboration with Neuropore on PD

18-01-2015

Neuropore Therapies, a wholly-owned US subsidiary of Austria’s Ever Neuro Pharma, has entered into…

Ever Neuro PharmaGlobalLicensingNeurologicalNeuropore TherapiesNPT200-11PharmaceuticalResearchUCB

Prices for vital and essential drugs may be frozen in Russia

18-01-2015

Prices for vital and essential drugs will not be a subject of currency fluctuations, according to recent…

PharmaceuticalPoliticsPricingProductionRussia

England's cancer outcomes worse than rest of Europe: National Audit Office report

England's cancer outcomes worse than rest of Europe: National Audit Office report

16-01-2015

The UK’s National Audit Office has published a report, Progress in improving cancer services and outcomes…

Markets & MarketingOncologyPharmaceuticalPoliticsPricingResearchUK

OncoGenex’ Ph III custirsen trial cleared to continue

16-01-2015

Canada’s OncoGenex Pharmaceuticals says that the AFFINITY trial is continuing as planned based upon…

custirsenOncoGenex PharmaceuticalsOncologyPharmaceuticalResearch

WuXi acquires NextCODE Health in $65 million cash deal

WuXi acquires NextCODE Health in $65 million cash deal

16-01-2015

Shanghai-headquartered pharmatech company WuXi has acquired NextCODE Health, a genomic analysis and bioinformatics…

ChinaMergers & AcquisitionsNextCODE HealthPharmaceuticalWuXi PharmaTech

EC approves AbbVie’s Viekirax + Exviera for hepatitis C

EC approves AbbVie’s Viekirax + Exviera for hepatitis C

16-01-2015

The European Commission has granted marketing authorizations for US drugmaker AbbVie’s all-oral, short-course,…

AbbVieAnti-viralsEuropeExvieraPharmaceuticalRegulationViekirax

Court orders SIGA to pay $195,000 in case brought by PharmAthene for Tecovirimat

Court orders SIGA to pay $195,000 in case brought by PharmAthene for Tecovirimat

16-01-2015

The Delaware Court of Chancery has entered its Final Order and Judgment in the case brought by US pharma…

Anti-viralsLegalPharmaceuticalPharmAtheneSIGA TechnologiesTecovirimatUSA

Depomed pays over $1 billion for US rights to Janssen’s Nucynta franchise

Depomed pays over $1 billion for US rights to Janssen’s Nucynta franchise

16-01-2015

US specialty drugmaker Depomed has entered into a definitive agreement to acquire the US rights to the…

DepomedGrunenthalJanssenJohnson & JohnsonLicensingNeurologicalNucyntaPharmaceuticalUSA

GlobalData believes Shire-NPS deal to be 'robust'

GlobalData believes Shire-NPS deal to be 'robust'

15-01-2015

Ireland-headquartered drugmaker Shire’s deal to acquire NPS Pharmaceuticals is ‘robust’, according…

GattexGlobalDataMergers & AcquisitionsNatparaNPS PharmaceuticalsPharmaceuticalRare diseasesResearchShire

Baby boomers and BRICS will boost industry in 2015, report predicts

Baby boomers and BRICS will boost industry in 2015, report predicts

15-01-2015

The biggest trends in the health care industry in 2014 are expected to develop further in 2015, according…

GlobalHealthcareInternational relationsMarketResearch.comPharmaceutical

High turnover and protocol noncompliance continue to plague the global investigative site landscape, says Tufts CSDD

15-01-2015

Global clinical trial performance and efficiency are hampered by high turnover and noncompliance among…

ManagementPharmaceuticalResearchUSA

EXPERT VIEW: Who are you hiring and acquiring? People risks in pharma

EXPERT VIEW: Who are you hiring and acquiring? People risks in pharma

15-01-2015

The pharmaceutical industry faces a number of unique challenges when recruiting staff. Unlike in many…

BoardroomGlobalHireRightPharmaceuticalPharmacology

Eric Terhaerdt appointed senior vice president of global development operations at Astellas

Eric Terhaerdt appointed senior vice president of global development operations at Astellas

15-01-2015

Japanese drug major Astellas Pharma has appointed Eric Terhaerdt as senior vice president of global development…

AstellasAstellas PharmaBoardroomEric TerhaerdtJapanPharmaceutical

FDA committee votes to not recommend Ferring’s desmopressin

FDA committee votes to not recommend Ferring’s desmopressin

15-01-2015

The US Food and Drug Administration Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC) has…

desmopressinFerring PharmaceuticalsGastro-intestinalsPharmaceuticalRegulationUSA

Sanofi enters strategic agreement with Boehringer Ingelheim on monoclonal antibodies

Sanofi enters strategic agreement with Boehringer Ingelheim on monoclonal antibodies

15-01-2015

French pharma major Sanofi has entered into a strategic agreement with German family-owned peer Boehringer…

Boehringer IngelheimGermanyLicensingPharmaceuticalResearchSanofi

76 to 100 of 7208 results

Back to top